These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Postnatal glucocorticoid therapy for prevention of bronchopulmonary dysplasia: routes of administration compared. Cole CH Semin Neonatol; 2001 Aug; 6(4):343-50. PubMed ID: 11972435 [TBL] [Abstract][Full Text] [Related]
44. Current strategies in the management of bronchopulmonary dysplasia: the role of corticosteroids. Knoppert DC; Mackanjee HR Neonatal Netw; 1994 Apr; 13(3):53-60. PubMed ID: 8152411 [TBL] [Abstract][Full Text] [Related]
45. Management of infants with bronchopulmonary dysplasia in North America. Bancalari E; Wilson-Costello D; Iben SC Early Hum Dev; 2005 Feb; 81(2):171-9. PubMed ID: 15748972 [TBL] [Abstract][Full Text] [Related]
47. Anti-inflammatory therapy in the neonatal intensive care unit: present and future. Watterberg K Semin Fetal Neonatal Med; 2006 Oct; 11(5):378-84. PubMed ID: 16632414 [TBL] [Abstract][Full Text] [Related]
48. Potential Nutrients for Preventing or Treating Bronchopulmonary Dysplasia. Ma L; Zhou P; Neu J; Lin HC Paediatr Respir Rev; 2017 Mar; 22():83-88. PubMed ID: 27843119 [TBL] [Abstract][Full Text] [Related]
49. Prevention and management of bronchopulmonary dysplasia: Lessons learned from the neonatal research network. Kennedy KA; Cotten CM; Watterberg KL; Carlo WA Semin Perinatol; 2016 Oct; 40(6):348-355. PubMed ID: 27742002 [TBL] [Abstract][Full Text] [Related]
50. [Research advance in prevention and treatment of bronchopulmonary dysplasia in premature infants]. Xuan Z; Xue XD; Fu JH Zhongguo Dang Dai Er Ke Za Zhi; 2010 May; 12(5):412-6. PubMed ID: 20497659 [No Abstract] [Full Text] [Related]
51. Bronchopulmonary dysplasia: clinical perspective. Jain D; Bancalari E Birth Defects Res A Clin Mol Teratol; 2014 Mar; 100(3):134-44. PubMed ID: 24578124 [TBL] [Abstract][Full Text] [Related]
53. Long-term sequelae of postnatal surfactant and corticosteroid therapies for BPD. Short EJ; Kirchner HL; Asaad GR; Fulton S; Lewis B; Eisengart S; Baley J; Kercsmar C; Min MO; Singer LT J Perinatol; 2008 Jul; 28(7):498-504. PubMed ID: 18368061 [TBL] [Abstract][Full Text] [Related]
54. Vitamin A supplementation in late pregnancy can decrease the incidence of bronchopulmonary dysplasia in newborns. Babu TA; Sharmila V J Matern Fetal Neonatal Med; 2010 Dec; 23(12):1468-9. PubMed ID: 20298108 [TBL] [Abstract][Full Text] [Related]
55. The effect of inhaled nitric oxide on pulmonary function in preterm infants. Di Fiore JM; Hibbs AM; Zadell AE; Merrill JD; Eichenwald EC; Puri AR; Mayock DE; Courtney SE; Ballard RA; Martin RJ J Perinatol; 2007 Dec; 27(12):766-71. PubMed ID: 17805339 [TBL] [Abstract][Full Text] [Related]
56. Drug treatment for bronchopulmonary dysplasia in Japan: questionnaire survey. Ogawa R; Mori R; Sako M; Kageyama M; Tamura M; Namba F Pediatr Int; 2015; 57(1):189-92. PubMed ID: 25711265 [TBL] [Abstract][Full Text] [Related]
57. Shielding parenteral nutrition from light: does the available evidence support a randomized, controlled trial? Sherlock R; Chessex P Pediatrics; 2009 Jun; 123(6):1529-33. PubMed ID: 19482764 [TBL] [Abstract][Full Text] [Related]
58. [Bronchopulmonary dysplasia in ex-prematures approaching adulthood]. Vrijlandt EJ; Gerritsen J; Duiverman EJ Ned Tijdschr Geneeskd; 2007 Nov; 151(44):2445-51. PubMed ID: 18064864 [TBL] [Abstract][Full Text] [Related]
59. Inhaled nitric oxide in the premature newborn. Kinsella JP; Abman SH J Pediatr; 2007 Jul; 151(1):10-5. PubMed ID: 17586183 [No Abstract] [Full Text] [Related]